Sedation Effect of Dexmedetomidine Versus Remifentanil to Fibreoptic Intubation

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Intubation; Difficult
Interventions
DRUG

dexmedetomidine group

1-1.5cmg/kg dexmedetomidine infusion within 10 minutes, while followed by maintainly infusing 0.7cmg/kg/min dexmedetomidine

DRUG

remifentanil group

target controlled 3.5-4ng/ml remifentanil infused(blood plasma concentration)

Trial Locations (2)

200011

Shanghai JiaoTong University, School of Medicine, Shanghai

Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

OTHER

NCT01474213 - Sedation Effect of Dexmedetomidine Versus Remifentanil to Fibreoptic Intubation | Biotech Hunter | Biotech Hunter